Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

PRE-DETERMINARE Studio di coorte

10 novembre 2026 aggiornato da: Christine M. Albert, MD, MPH, Brigham and Women's Hospital

PRE-DETERMINARE: Marcatori biologici e studio di coorte MRI SCD

This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.

Panoramica dello studio

Descrizione dettagliata

The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.

Tipo di studio

Osservativo

Iscrizione (Effettivo)

5764

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Alberta
      • Edmonton, Alberta, Canada, T6G 2B7
        • University of Alberta
    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 1M9
        • Vancouver General Hospital
    • Ontario
      • Mississauga, Ontario, Canada, L5B 2P7
        • Mississauga Clinical Research Centre
      • Rio Piedras, Porto Rico, 00924
        • Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe
    • Alaska
      • Anchorage, Alaska, Stati Uniti, 99508
        • Alaska Heart Institute
    • Arizona
      • Glendale, Arizona, Stati Uniti, 85306
        • Phoenix Heart, PLLC
      • Phoenix, Arizona, Stati Uniti, 85032
        • Cardiovascular Consultants
    • California
      • Banning, California, Stati Uniti, 92220
        • Beaver Medical Group/Clinical Care Research
    • Colorado
      • Colorado Springs, Colorado, Stati Uniti, 80909
        • Memorial Health System
      • Denver, Colorado, Stati Uniti, 80204
        • Colorado Heart and Vascular
    • Florida
      • Brandon, Florida, Stati Uniti, 33511
        • Bay Area Cardiology Associates, P.A.
      • Gainesville, Florida, Stati Uniti, 32610
        • University of Florida - Gainsville
      • Miami, Florida, Stati Uniti, 33135
        • Reliable Clinical Research
      • Miami Beach, Florida, Stati Uniti, 33140
        • Mount Sinai Medical Center
      • Orlando, Florida, Stati Uniti, 32804
        • Florida Hospital
      • Orlando, Florida, Stati Uniti, 32806
        • Orlando Regional Medical Center
      • Palm Beach Gardens, Florida, Stati Uniti, 33410
        • Palm Beach Gardens Research Center
      • Sarasota, Florida, Stati Uniti, 34233
        • Velella Research
      • Tallahassee, Florida, Stati Uniti, 32308
        • Tallahassee Research Institute, Inc.
      • West Palm Beach, Florida, Stati Uniti, 33401
        • Cardiology Associates of Palm Beach - West Palm Beach
    • Georgia
      • Covington, Georgia, Stati Uniti, 30014
        • Georgia Heart Specialist
      • Gainesville, Georgia, Stati Uniti, 30501
        • Northeast Georgia Heart Center, P.C.
    • Illinois
      • Chicago, Illinois, Stati Uniti, 60637
        • University of Chicago
      • Chicago, Illinois, Stati Uniti, 60643
        • Advocate Medical Group
      • Chicago, Illinois, Stati Uniti, 60657
        • Advocate Medical Group - Heart and Vascular of IL
      • Melrose Park, Illinois, Stati Uniti, 60160
        • Consultants in Cardiovascular Medicine
    • Indiana
      • Anderson, Indiana, Stati Uniti, 46011
        • Community Heart and Vascular
    • Iowa
      • West Des Moines, Iowa, Stati Uniti, 50266
        • Iowa Heart Center
    • Kansas
      • Kansas City, Kansas, Stati Uniti, 66160
        • The University of Kansas
    • Kentucky
      • Lexington, Kentucky, Stati Uniti, 40503
        • Baptist Health Lexington
    • Louisiana
      • Houma, Louisiana, Stati Uniti, 70363
        • Leonard J. Chabert Medical Center
    • Maine
      • Auburn, Maine, Stati Uniti, 04210
        • Maine Research Associates
      • Lewiston, Maine, Stati Uniti, 04240
        • Maine Research Associates - Lewiston
    • Maryland
      • Baltimore, Maryland, Stati Uniti, 21201
        • University of Maryland Medical Center
    • Massachusetts
      • Ayer, Massachusetts, Stati Uniti, 01432
        • Primary Care Cardiology Research
      • Boston, Massachusetts, Stati Uniti, 02115
        • Brigham and Women's Hospital
      • Fall River, Massachusetts, Stati Uniti, 02720
        • NECCR Internal Medicine and Cardiology Associates, LLC
      • North Dartmouth, Massachusetts, Stati Uniti, 02747
        • Hawthorn Medical Associates
      • Springfield, Massachusetts, Stati Uniti, 01199
        • Baystate Cardiology
    • Michigan
      • Ann Arbor, Michigan, Stati Uniti, 48109
        • University of Michigan Medical Center
      • Dearborn, Michigan, Stati Uniti, 48124
        • Oakwood Hospital & Medical Center
      • Mount Clemens, Michigan, Stati Uniti, 48043
        • McLaren Medical Center - Macomb
      • Ypsilanti, Michigan, Stati Uniti, 48197
        • Michigan Heart
    • Minnesota
      • Minneapolis, Minnesota, Stati Uniti, 55417
        • Minneapolis VA Medical Center
    • Missouri
      • Columbia, Missouri, Stati Uniti, 65201
        • University of Missouri Health Care
    • Montana
      • Kalispell, Montana, Stati Uniti, 59901
        • Glacier View Cardiology
    • Nebraska
      • Omaha, Nebraska, Stati Uniti, 68131
        • The Cardiac Center of Creighton University
    • New Jersey
      • Bridgewater, New Jersey, Stati Uniti, 08807
        • Advanced Heartcare, LLC
      • Paterson, New Jersey, Stati Uniti, 07503
        • St. Joseph Regional Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Stati Uniti, 87108
        • New Mexico VA Healthcare Systems
    • New York
      • Albany, New York, Stati Uniti, 12205
        • Albany Associates Cardiology
      • Brooklyn, New York, Stati Uniti, 11219
        • Maimonides Medical Center
      • Buffalo, New York, Stati Uniti, 14203
        • Buffalo General Hospital/Kaleida Health
      • Jamaica, New York, Stati Uniti, 11418
        • Jamaica Hospital Medical Center
      • Kingston, New York, Stati Uniti, 12401
        • Mid-Valley Cardiology
      • Mineola, New York, Stati Uniti, 11501
        • Winthrop-University Hospital
      • New York, New York, Stati Uniti, 10001
        • Gotham Cardiovascular
      • New York, New York, Stati Uniti, 10032
        • Columbia University Health Center
      • Stony Brook, New York, Stati Uniti, 11794
        • Stony Brook University Medical Center
      • Utica, New York, Stati Uniti, 13501
        • St. Elizabeth Medical Center - Hotvedt
    • North Carolina
      • Asheville, North Carolina, Stati Uniti, 28801
        • Asheville Cardiology Associates
      • Elizabeth City, North Carolina, Stati Uniti, 27909
        • Eastern Carolina Cardiovascular
      • Lenoir, North Carolina, Stati Uniti, 28645
        • Northstate Clinical Research
      • Pinehurst, North Carolina, Stati Uniti, 28374
        • Pinehurst Medical Clinic, Inc.
      • Sanford, North Carolina, Stati Uniti, 27330
        • Sanford Cardiology
      • Winston-Salem, North Carolina, Stati Uniti, 27157
        • Wake Forest
    • Ohio
      • Akron, Ohio, Stati Uniti, 44304
        • Northeast Ohio Cardiovascular Specialists
      • Cincinnati, Ohio, Stati Uniti, 45267
        • University of Cincinnati
      • Cleveland, Ohio, Stati Uniti, 44109
        • MetroHealth Medical Center
      • Elyria, Ohio, Stati Uniti, 44035
        • North Ohio Research, Ltd.
      • Fairfield, Ohio, Stati Uniti, 45014
        • Mercy Medical Associates
      • Toledo, Ohio, Stati Uniti, 43615
        • Northwest Ohio Cardiology Consultants/The Toledo Hospital
    • Oklahoma
      • Oklahoma City, Oklahoma, Stati Uniti, 73120
        • Oklahoma Foundation for Cardiovascular Research
      • Oklahoma City, Oklahoma, Stati Uniti, 73104
        • Oklahoma City VA Medical Center Veterans Research and Education Foundation
    • Pennsylvania
      • Abington, Pennsylvania, Stati Uniti, 19001
        • Abington Memorial Hospital
      • Bethlehem, Pennsylvania, Stati Uniti, 18018
        • St. Luke's Bethlehem
      • Doylestown, Pennsylvania, Stati Uniti, 18901
        • Doylestown Cardiology Associates
      • Pittsburgh, Pennsylvania, Stati Uniti, 15212
        • Allegheny General Hospital
      • Pittsburgh, Pennsylvania, Stati Uniti, 15213
        • University of Pittsburgh Medical Center
    • South Carolina
      • Anderson, South Carolina, Stati Uniti, 29621
        • AnMed Health
      • Charleston, South Carolina, Stati Uniti, 29425
        • VA Medical Center - Charleston
      • Rock Hill, South Carolina, Stati Uniti, 29732
        • Carolina Cardiology Associates
    • South Dakota
      • Rapid City, South Dakota, Stati Uniti, 57701
        • Black Hills Cardiovascular Research
    • Tennessee
      • Knoxville, Tennessee, Stati Uniti, 37917
        • Cardiovasular Research of Knoxville
      • Memphis, Tennessee, Stati Uniti, 38104
        • Memphis VA Medical Center
    • Texas
      • Houston, Texas, Stati Uniti, 77030
        • St. Luke's Episcopal Hospital
      • Houston, Texas, Stati Uniti, 77074
        • Non-Invasive Cardiovascular PA
      • Waco, Texas, Stati Uniti, 76712
        • Providence Health Center
    • Utah
      • Murray, Utah, Stati Uniti, 84157
        • Intermountain Medical Center
    • Virginia
      • Virginia Beach, Virginia, Stati Uniti, 23454
        • Cardiovascular Associates Virginia Beach

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione di probabilità

Popolazione di studio

Participants have been recruited throughout multicenter sites participating in the PRE-DETERMINE Cohort Study. Patients with a history of coronary artery disease and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%) have been enrolled. The clinical study staff at each site, which was either a research nurse, fellow, or physician approached eligible patients to discuss their potential participation.

Descrizione

Inclusion Criteria:

  1. Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.

  2. LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.

  3. If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.

  4. Patients aged 18 years or above

    1. CAD will be defined as evidence of one of the following two (2) criteria:

      • Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography
      • Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)
    2. MI can be documented in the following ways:

      • From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:

        • Symptoms of Ischemia
        • ECG changes indicative of new ischemia (new ST-T changes or new LBBB)
        • Development of pathological Q waves
        • Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
      • If no report from the MI hospitalization is available, prior MI can be met by either of the following:

        • Development of pathological Q waves
        • Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause

Exclusion Criteria:

  1. History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).
  2. Unexplained syncope
  3. Current or planned implantable cardiac defibrillator (ICD)
  4. Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)
  5. Metastatic cancer
  6. Marked valvular heart disease requiring surgical intervention
  7. Current or planned cardiac, renal or liver transplant
  8. Current alcohol or drug abuse
  9. Unwilling or unable to provide informed consent
  10. LVEF <35% with Class II-IV CHF or LVEF <30%
  11. Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation.
Lasso di tempo: Median follow-up estimated to be 10.7 years

A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation.

Median follow-up estimated to be 10.7 years

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Impianto ICD
Lasso di tempo: Il follow-up mediano è stato stimato in 10,7 anni
Il follow-up mediano è stato stimato in 10,7 anni
Mortalità cardiaca totale
Lasso di tempo: Il follow-up mediano è stato stimato in 10,7 anni
Il follow-up mediano è stato stimato in 10,7 anni
Mortalità totale
Lasso di tempo: Il follow-up mediano è stato stimato in 10,7 anni
Il follow-up mediano è stato stimato in 10,7 anni
ICD Shock
Lasso di tempo: Median follow-up estimated to be 10.7 years

ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint.

Median follow-up estimated to be 10.7 years
Non-Sudden or Arrhythmic Causes of Mortality
Lasso di tempo: Median follow-up estimated to be 10.7 years

Competing causes of mortality in competing risk analyses.

Median follow-up estimated to be 10.7 years

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Christine M Albert, M.D., M.P.H., Brigham and Women's Hospital

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 luglio 2007

Completamento primario (Stimato)

1 novembre 2027

Completamento dello studio (Stimato)

1 novembre 2027

Date di iscrizione allo studio

Primo inviato

29 aprile 2010

Primo inviato che soddisfa i criteri di controllo qualità

29 aprile 2010

Primo Inserito (Stimato)

3 maggio 2010

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi